These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23344700)

  • 1. Emergency department visits and hospitalizations for buprenorphine ingestion by children--United States, 2010-2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2013 Jan; 62(3):56. PubMed ID: 23344700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notes from the Field: Pediatric Emergency Department Visits for Buprenorphine/Naloxone Ingestion - United States, 2008-2015.
    Budnitz DS; Lovegrove MC; Sapiano MR; Mathew J; Kegler SR; Geller AI; Hampp C
    MMWR Morb Mortal Wkly Rep; 2016 Oct; 65(41):1148-1149. PubMed ID: 27764078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboxone (buprenorphine/naloxone) toxicity in pediatric patients: a case report.
    Schwarz KA; Cantrell FL; Vohra RB; Clark RF
    Pediatr Emerg Care; 2007 Sep; 23(9):651-2. PubMed ID: 17876257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity of buprenorphine overdoses in children.
    Hayes BD; Klein-Schwartz W; Doyon S
    Pediatrics; 2008 Apr; 121(4):e782-6. PubMed ID: 18381506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of heroin overdose reversed by sublingually administered buprenorphine/naloxone (Suboxone).
    Welsh C; Sherman SG; Tobin KE
    Addiction; 2008 Jul; 103(7):1226-8. PubMed ID: 18554353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underrecognized toll of prescription opioid abuse on young children.
    Bailey JE; Campagna E; Dart RC;
    Ann Emerg Med; 2009 Apr; 53(4):419-24. PubMed ID: 18774623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse effects in children after unintentional buprenorphine exposure.
    Geib AJ; Babu K; Ewald MB; Boyer EW
    Pediatrics; 2006 Oct; 118(4):1746-51. PubMed ID: 17015570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine poisoning in children: a 10-year-experience of Marseille Poison Center.
    von Fabeck K; Boulamery A; Glaizal M; de Haro L; Simon N
    Fundam Clin Pharmacol; 2020 Apr; 34(2):265-269. PubMed ID: 31675453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
    Alho H; Sinclair D; Vuori E; Holopainen A
    Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with fortnightly buprenorphine/naloxone versus buprenorphine in Italy: preliminary observational data in an office-based setting.
    Amato P
    Clin Drug Investig; 2010; 30 Suppl 1():33-9. PubMed ID: 20450244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Formulary Prior Authorization Policies With Buprenorphine-Naloxone Prescriptions and Hospital and Emergency Department Use Among Medicare Beneficiaries.
    Mark TL; Parish WJ; Zarkin GA
    JAMA Netw Open; 2020 Apr; 3(4):e203132. PubMed ID: 32310285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ingestion of Over-the-Counter Liquid Medications: Emergency Department Visits by Children Aged Less Than 6 Years, 2012-2015.
    Lovegrove MC; Weidle NJ; Budnitz DS
    Am J Prev Med; 2019 Feb; 56(2):288-292. PubMed ID: 30573336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal buprenorphine intoxication.
    Magdalan J; Merwid-Lad A
    Clin Toxicol (Phila); 2008 Nov; 46(9):915-6. PubMed ID: 18608275
    [No Abstract]   [Full Text] [Related]  

  • 14. At-a-glance - Hospitalizations and emergency department visits due to opioid poisoning in Canada.
    O'Connor S; Grywacheski V; Louie K
    Health Promot Chronic Dis Prev Can; 2018 Jun; 38(6):244-247. PubMed ID: 29911820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder.
    Herring AA; Schultz CW; Yang E; Greenwald MK
    Am J Emerg Med; 2019 Dec; 37(12):2259-2262. PubMed ID: 31239086
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-marketing surveillance of methadone and buprenorphine in the United States.
    Dasgupta N; Bailey EJ; Cicero T; Inciardi J; Parrino M; Rosenblum A; Dart RC
    Pain Med; 2010 Jul; 11(7):1078-91. PubMed ID: 20545875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unintentional methadone and buprenorphine exposures in children: Developing prevention messages.
    Schwartz L; Mercurio-Zappala M; Howland MA; Hoffman RS; Su MK
    J Am Pharm Assoc (2003); 2017; 57(2S):S83-S86. PubMed ID: 28292505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children.
    Lavonas EJ; Banner W; Bradt P; Bucher-Bartelson B; Brown KR; Rajan P; Murrelle L; Dart RC; Green JL
    J Pediatr; 2013 Nov; 163(5):1377-83.e1-3. PubMed ID: 23993129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical effects of unintentional pediatric buprenorphine exposures: experience at a single tertiary care center.
    Toce MS; Burns MM; O'Donnell KA
    Clin Toxicol (Phila); 2017 Jan; 55(1):12-17. PubMed ID: 27756148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Unit-Dose Child-Resistant Packaging in Unintentional Childhood Exposures to Buprenorphine-Naloxone Tablets.
    Hampp C; Lovegrove MC; Budnitz DS; Mathew J; Ho A; McAninch J
    Drug Saf; 2020 Feb; 43(2):189-191. PubMed ID: 31745829
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.